Project Grant R01EY036478

Award Date 9/30/24
Completion Date 6/30/28
Dollars Obligated $1.1M
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92617, USA
Similar Awards
This federal Project Grant award of $247,700.00 from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports the establishment of a chimeric mouse model to study human retinal microglia in vivo. The key objectives are to: Characterize the engraftment and impact of xenotransplanted human microglia in the mouse retina and optic nerve. Use single-cell RNA sequencing to define the transcriptome of the human xenotransplanted microglia and analyze their responses to...
The National Eye Institute (NEI) awarded a $488,639 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of Pittsburgh to identify the mechanisms underlying the enhanced virulence of an extensively drug-resistant (XDR) strain of Pseudomonas aeruginosa that has caused a concerning outbreak of keratitis infections. The funding will support research to systematically test the unique virulence factors of this outbreak strain and develop more effective...
This Project Grant award of $2,174,069 from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) supports research to elucidate the regenerative potential of the corneal endothelium and develop innovative mRNA-based therapies for Fuchs' Endothelial Corneal Dystrophy (FECD). The primary awardee, the University of Pennsylvania, will utilize advanced imaging, genetic mouse models, and mRNA technology to investigate CEC proliferation and signaling pathways, with the...
This Project Grant award from the National Eye Institute (CFDA Program 93.867 - Vision Research) will provide $588,731 to The University of Iowa to conduct research on Fuchs Endothelial Corneal Dystrophy (FECD). The research aims to investigate how genetic and environmental factors, such as guttae buildup and UV-A exposure, drive ferroptosis - a form of cell death - in corneal endothelial cells, leading to vision loss in FECD patients. The research team will utilize human tissues, primary cells,...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will fund research at the University of California, San Francisco (UCSF) to study the neural mechanisms of sensory encoding after photoreceptor degeneration. The $237,588 award, effective June 1, 2025 through December 31, 2027, will leverage the vertical optokinetic reflex, a visual behavior that tracks global motion, to investigate how cone degeneration disrupts noise...
This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports research to investigate the role of the Optineurin (OPTN) gene in Herpes Simplex Virus Type-1 (HSV-1) infection and its impact on corneal health and sensory nerve function. The $637,333 award to the University of Illinois aims to comprehensively study the molecular mechanisms by which OPTN regulates viral degradation, antigen presentation, and the innate-adaptive...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), supports research to develop a novel, laser-based approach for non-viral corneal gene delivery. The $431,750 award to the University of California, Irvine aims to create microscale channels through the corneal epithelium to enhance transepithelial diffusion, and use femtosecond laser pulses to permeabilize stromal cells for plasmid-based gene delivery, without the risks associated...
This federal Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) will support research to investigate the role of the opsin protein OPN5 in modulating corneal wound healing through light-dependent mechanisms. The total funding amount is $441,250, with a project period from September 1, 2024 to May 31, 2029. The key objectives of this project are to: 1) Test the light regimen necessary for accelerating corneal wound healing in mice, 2)...
The National Eye Institute (NEI) awarded a $974,348 Project Grant under the Vision Research federal grant program (CFDA 93.867) to Wayne State University to conduct metabolomics research on bacterial and fungal endophthalmitis, a devastating eye infection that can lead to vision loss. The primary goals of the 4-year project are to: Perform untargeted metabolomics analysis on vitreous samples from patients with culture-positive bacterial and fungal endophthalmitis to identify unique metabolic...
This Project Grant award from the National Eye Institute (NEI), under the federal Vision Research program (CFDA 93.867), will provide $246,000 to The Regents of the University of California, San Francisco (UCSF) to conduct research on identifying and characterizing the bioactive components in serum that can support corneal health and repair. The key objectives are to define the combinations of serum components, such as growth factors, signaling lipids, and vitamins, that are most effective in...

This federal Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), will provide $1,083,078.00 to the University of California, Irvine (UC Irvine) over the period of September 30, 2024 to June 30, 2028. The project aims to examine the role of monocytes and neutrophils in fungal keratitis, a leading cause of corneal blindness and vision loss. Key objectives include investigating neutrophil activation and the effect of monocyte depletion on neutrophil anti-fungal activity, exploring the function of ICAM-1+ neutrophils, and examining the processing and role of pore-forming proteins in IL-1B secretion by neutrophils. The research will utilize murine models, single-cell RNA sequencing, and novel inhibitors to advance the understanding of fungal keratitis pathogenesis and identify potential targets for immune intervention.

Generated 7/15/25, 3:56 AM